Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H DEICHER

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
Deutsche Medizinische Wochenschrift (1946)|May 20, 1977
[Prophylaxis of Rh-sensitisation by intravenous IgG anti-D (author's transl)]P Börner, H Deicher, I Bähr, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Prognostic value of clinical, laboratory, and histological characteristics in multiple myeloma: improved definition of risk groupsD Peest, R Coldewey, H Deicher, et al.
Clinical and Experimental Immunology|June 1, 1978
Influence of continuous-flow blood separator leucophoresis on in vitro functions of human lymphocytesH C Siewertsen, H H Peter, J R Kalden, et al.
Rheumatology International|January 1, 1992
MHC associations of autoantibodies against recombinant Ro and La proteins in systemic lupus erythematosus. Results of a multicenter study. SLE Study GroupH Ehrfeld, K Hartung, M Renz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment GroupD Peest, H Deicher, R Coldewey, et al.
The Journal of Clinical Investigation|September 1, 1993
Defect of a complement receptor 3 epitope in a patient with systemic lupus erythematosusT Witte, F L Dumoulin, J E Gessner, et al.
Autoimmunity|January 1, 1992
MHC gene products and anticardiolipin antibodies in systemic lupus erythematosus results of a multicenter study. SLE Study GroupK Hartung, R Coldewey, A Corvetta, et al.
Rheumatology International|January 1, 1995
Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations. The SLE Study GroupC Sachse, K Lüthke, K Hartung, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1996
Pyridinium cross-links in multiple myeloma: correlation with clinical parameters and use for monitoring of intravenous clodronate therapy--a pilot study of the German Myeloma Treatment Group (GMTG)D Peest, H Deicher, W Fett, et al.
Genetic Epidemiology|January 1, 1991
Testing for association in SLE familiesS A Seuchter, M Knapp, K Hartung, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Deutsche Medizinische Wochenschrift (1946)|May 20, 1977
[Prophylaxis of Rh-sensitisation by intravenous IgG anti-D (author's transl)]P Börner, H Deicher, I Bähr, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Prognostic value of clinical, laboratory, and histological characteristics in multiple myeloma: improved definition of risk groupsD Peest, R Coldewey, H Deicher, et al.
Clinical and Experimental Immunology|June 1, 1978
Influence of continuous-flow blood separator leucophoresis on in vitro functions of human lymphocytesH C Siewertsen, H H Peter, J R Kalden, et al.
Rheumatology International|January 1, 1992
MHC associations of autoantibodies against recombinant Ro and La proteins in systemic lupus erythematosus. Results of a multicenter study. SLE Study GroupH Ehrfeld, K Hartung, M Renz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment GroupD Peest, H Deicher, R Coldewey, et al.
The Journal of Clinical Investigation|September 1, 1993
Defect of a complement receptor 3 epitope in a patient with systemic lupus erythematosusT Witte, F L Dumoulin, J E Gessner, et al.
Autoimmunity|January 1, 1992
MHC gene products and anticardiolipin antibodies in systemic lupus erythematosus results of a multicenter study. SLE Study GroupK Hartung, R Coldewey, A Corvetta, et al.
Rheumatology International|January 1, 1995
Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations. The SLE Study GroupC Sachse, K Lüthke, K Hartung, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1996
Pyridinium cross-links in multiple myeloma: correlation with clinical parameters and use for monitoring of intravenous clodronate therapy--a pilot study of the German Myeloma Treatment Group (GMTG)D Peest, H Deicher, W Fett, et al.
Genetic Epidemiology|January 1, 1991
Testing for association in SLE familiesS A Seuchter, M Knapp, K Hartung, et al.
Pageof 14